{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihpm3d75yhinwevnvegvvvg7kdqs6bpbme7xxzqz2tkd6z2fh7omy",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mgnbbus25aj2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihg4jxco4huklldm5ahsuok2dlfmis4tw5etgowyiwdxjjmzpz5pe"
    },
    "mimeType": "image/jpeg",
    "size": 1651
  },
  "path": "/story/385053/novo-nordisk-drops-lawsuit-vs-hims-hers-inks-sales-deal.html",
  "publishedAt": "2026-03-09T10:51:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "Novo Nordisk just swapped a courtroom fight for a sales deal with Hims & Hers—and investors loved it, reports CNBC . The Danish drugmaker has dropped its patent-infringement case against the telehealth company after Hims agreed to sell Novo's branded weight-loss drugs Ozempic and Wegovy through its platform, at prices...",
  "title": "The Novo Nordisk-Hims & Hers Feud Is Over"
}